[go: up one dir, main page]

NO20061764L - En farmasoytisk sammensetning for behandling av kadiovaskulaere og cerebrovaskulaere sykdommer - Google Patents

En farmasoytisk sammensetning for behandling av kadiovaskulaere og cerebrovaskulaere sykdommer

Info

Publication number
NO20061764L
NO20061764L NO20061764A NO20061764A NO20061764L NO 20061764 L NO20061764 L NO 20061764L NO 20061764 A NO20061764 A NO 20061764A NO 20061764 A NO20061764 A NO 20061764A NO 20061764 L NO20061764 L NO 20061764L
Authority
NO
Norway
Prior art keywords
composition
present
treatment
pharmaceutical composition
extract
Prior art date
Application number
NO20061764A
Other languages
English (en)
Other versions
NO334431B1 (no
Inventor
Feng Wei
Dekun Li
Chongnian Luo
Hongshui Yue
Qingchuang Chen
Zhijuan Huang
Original Assignee
Tianjin Tasly Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Tasly Pharmaceutical filed Critical Tianjin Tasly Pharmaceutical
Publication of NO20061764L publication Critical patent/NO20061764L/no
Publication of NO334431B1 publication Critical patent/NO334431B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Foreliggende oppfinnelse beskriver en farmasøytisk sammensetning for behandling av angiokardiopati som består av Radix Salviae Miltiorrhizae ekstrakt, 5,0 - 70,0 %, Radix Notoginseng ekstrakt, 10,0 - 85,0 %, Radix Astragali ekstrakt 5,0 - 70,0 %, og Bomeolum Suntheticum eller olje av Lignum Dalbergiae Odoferae, 1,0 - 15,0 %. Sammensetningen er aktiv mot cerebrale iskemi og myokardial iskemi. Effektene er overlegne i forhold til henholdsvis totale syrer fra Radix Salviae Miltiorrhiziae eller totale saponiner av Radix Notoginseng, eller kombinasjonen derav. Sammensetningen ifølge foreliggende oppfinnelse kan fremskaffe forskjellige typer preparater ved tilsetting av forskjellige hjelpestoffer. Således fremskaffer foreliggende oppfinnelse en mer effektiv og bekvem sammensetning av TCM effektive seksjoner og dets preparater.
NO20061764A 2003-09-23 2006-04-21 Farmasøytisk sammensetning for behandling av kadiovaskulær eller cerebrovaskulær sykdom, inneholdende planteekstrakter samt anvendelse av samme. NO334431B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB031443117A CN100339085C (zh) 2003-09-23 2003-09-23 治疗心脑血管疾病的中药组合物
PCT/CN2004/001085 WO2005051404A1 (fr) 2003-09-23 2004-09-23 Composition pharmaceutique pour le traitement de l'angiocardiopathie

Publications (2)

Publication Number Publication Date
NO20061764L true NO20061764L (no) 2006-05-22
NO334431B1 NO334431B1 (no) 2014-03-03

Family

ID=34624426

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061764A NO334431B1 (no) 2003-09-23 2006-04-21 Farmasøytisk sammensetning for behandling av kadiovaskulær eller cerebrovaskulær sykdom, inneholdende planteekstrakter samt anvendelse av samme.

Country Status (24)

Country Link
US (1) US7438935B2 (no)
EP (1) EP1679058B1 (no)
JP (1) JP4943846B2 (no)
KR (1) KR20070028283A (no)
CN (1) CN100339085C (no)
AP (1) AP1908A (no)
AT (1) ATE551100T1 (no)
AU (1) AU2004292351B2 (no)
BR (1) BRPI0414655B8 (no)
CA (1) CA2538478C (no)
DK (1) DK1679058T3 (no)
EA (1) EA009730B1 (no)
ES (1) ES2383599T3 (no)
LT (1) LT5433B (no)
MY (1) MY144043A (no)
NO (1) NO334431B1 (no)
NZ (1) NZ546654A (no)
PL (1) PL1679058T3 (no)
PT (1) PT1679058E (no)
SA (1) SA04250309B1 (no)
SI (1) SI1679058T1 (no)
UA (1) UA85065C2 (no)
WO (1) WO2005051404A1 (no)
ZA (1) ZA200603180B (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7884195B2 (en) * 2005-04-26 2011-02-08 Long Yun Li Method of extracting ginsengnoside Rg2m, pharmaceutical composition including ginsengnoside Rg2, and uses thereof
CN1305493C (zh) * 2005-06-09 2007-03-21 北京中医药大学 一种治疗脑中风的中药有效部位及其分离制备方法
CA2614700C (en) * 2005-07-14 2011-07-19 National Institute Of Pharmaceutical R&D Co., Ltd. Medicinal composition containing ginseng secondary glycosides, its preparation method and application
CN1919252B (zh) * 2005-08-24 2011-09-21 天津天士力制药股份有限公司 一种治疗心脑血管疾病的药物
CN1919237B (zh) * 2005-08-24 2011-10-05 天津天士力制药股份有限公司 治疗心脑血管疾病的药物
CN1919236B (zh) * 2005-08-24 2010-09-29 天津天士力制药股份有限公司 治疗心脑血管病的药物
CN1919235B (zh) * 2005-08-24 2010-12-01 天津天士力制药股份有限公司 治疗心脑血管疾病的药物组合物
CN1919253B (zh) * 2005-08-24 2010-12-01 天津天士力制药股份有限公司 一种治疗心脑血管疾病的药物组合物
CN1919238B (zh) * 2005-08-24 2011-10-05 天津天士力制药股份有限公司 一种治疗心脑血管病的药物
CN100400047C (zh) * 2006-04-05 2008-07-09 黑龙江省珍宝岛制药有限公司 一种用于治疗心脑血管疾病的粉针剂及其制备方法和应用
CN100563662C (zh) * 2006-11-28 2009-12-02 中国科学院上海药物研究所 治疗心血管疾病的中药有效成分组合物及其制备方法
CN101322801B (zh) 2007-06-15 2011-07-20 河北以岭医药研究院有限公司 一种中药组合物在制备治疗扩张型心肌病药物中的应用
CN101439078B (zh) * 2007-11-22 2012-03-28 天津天士力制药股份有限公司 一种含黄芪提取物的中药颗粒及其制备方法
CN101439079B (zh) * 2007-11-22 2012-04-18 天津天士力制药股份有限公司 一种含黄芪总皂甙的中药颗粒的制备方法
CN101439076B (zh) * 2007-11-22 2012-04-18 天津天士力制药股份有限公司 一种含降香油的中药颗粒的制备方法
CN101524352A (zh) 2008-03-04 2009-09-09 江苏先声药物研究有限公司 一种含有3-甲基-1-苯基-2-吡唑啉-5-酮的组合物
WO2010111935A1 (zh) * 2009-03-30 2010-10-07 天津天士力制药股份有限公司 一种新的丹酚酸化合物l、其制备方法和用途
CN102028748A (zh) * 2009-09-29 2011-04-27 天津天士力现代中药资源有限公司 一种治疗冠心病的药物及提取工艺
CN102028739B (zh) * 2009-09-29 2014-01-29 天津天士力现代中药资源有限公司 一种治疗冠心病的药物及其制备方法
KR101286870B1 (ko) 2009-11-30 2013-07-16 (주)아모레퍼시픽 황기 추출물을 포함하는 대사 촉진 조성물
CN102160872A (zh) * 2010-02-23 2011-08-24 天津天士力制药股份有限公司 复方丹参滴丸胶囊
CN102293821A (zh) * 2010-06-28 2011-12-28 天津天士力制药股份有限公司 一种中药组合物在制备减轻急性心肌梗死后心绞痛发作的药物中的应用
JP6030556B2 (ja) 2010-08-06 2016-11-24 タスリー・ファーマシューティカル・グループ・カンパニー・リミテッドＴａｓｌｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｇｒｏｕｐ Ｃｏ．， Ｌｔｄ． 冠動脈心疾患の二次予防薬の調製におけるタンジン組成物の使用
CN102670759A (zh) * 2012-05-18 2012-09-19 王显 治疗动脉粥样硬化的中药组合物
KR20140080289A (ko) * 2012-12-20 2014-06-30 대전대학교 산학협력단 산화적 뇌손상 및 뇌기능 장애의 예방 또는 치료용 조성물 및 이의 제조방법
CN103070909B (zh) * 2013-01-04 2015-07-29 云南金七制药有限公司 三芪软胶囊及其制备方法
EA034217B1 (ru) 2013-07-11 2020-01-17 Тасли Фармасьютикал Груп Ко., Лтд. Композиция традиционной китайской медицины, фармацевтический препарат и капельная микропилюля из нее, способ получения капельной микропилюли и применение композиции
DK3020395T3 (da) * 2013-07-11 2021-05-25 Tasly Pharmaceutical Group Co Fremgangsmåde til fremstilling af traditionel kinesisk medicin mikrodryppille og traditionel kinesisk medicin mikrodryppiller fremstillet ved anvendelse af fremgangsmåden
HUE072128T2 (hu) 2013-07-11 2025-10-28 Tasly Pharmaceutical Group Co Hagyományos kínai gyógyászati összetétel, és annak elõállítása és alkalmazása
CN104418744B (zh) 2013-08-29 2017-03-01 天士力制药集团股份有限公司 一种新的丹酚酸化合物t、其制备方法和用途
CN104013831B (zh) * 2014-06-05 2017-06-23 黄艳梅 一种治疗脑供血不足的药物
CN106632572B (zh) * 2016-12-16 2018-08-14 中国科学院成都生物研究所 一种黄芪甲苷衍生物及其制备方法和应用
KR101892392B1 (ko) 2017-06-12 2018-08-27 오형근 고혈압 및 당뇨 개선을 위한 조성물
CN107582977A (zh) * 2017-10-18 2018-01-16 海南梵思科技有限公司 一种治疗心血管疾病的中药组合物及其制备方法
FR3076458B1 (fr) * 2018-01-05 2022-06-24 Soc Ind Limousine Dapplication Biologique Utilisation cosmetique d'extraits de racines de salvia miltiorrhiza, extraits particuliers de racines de salvia miltiorrhiza et compositions cosmetiques incluant de tels extraits
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
TW201944990A (zh) * 2018-04-04 2019-12-01 大陸商天士力醫藥集團股份有限公司 預防和/或治療缺血再灌注損傷的中藥組合物及其製劑和應用
CN109394832A (zh) * 2018-10-29 2019-03-01 华玉海 一种治疗心脑血管病的复方滴丸及其制备方法
AU2021264907A1 (en) * 2020-04-29 2022-09-15 Tasly Pharmaceutical Group Co., Ltd. Traditional Chinese medicine composition, and application of preparation of traditional chinese medicine composition in preparing medicine for preventing and/or treating coronavirus disease 2019
CN113925892B (zh) * 2020-06-29 2024-04-09 天士力医药集团股份有限公司 中药芪参益气制剂治疗胃出血的用途
CN111991533A (zh) * 2020-09-11 2020-11-27 吉林省中医药科学院（吉林省中医药科学院第一临床医院） 一种治疗冠心病的中药组合物
WO2023045740A1 (zh) * 2021-09-27 2023-03-30 天士力医药集团股份有限公司 一种治疗心肌缺血的药物组合物及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59303061D1 (de) 1992-06-29 1996-08-01 Elpatronic Ag Verfahren zum Zuführen von Dosenzargen zu einer Dosenschweissstation sowie Vorrichtung zu dessen Durchführung
CN1025774C (zh) * 1992-11-14 1994-08-31 连汝安 一种特效型山海丹及其生产方法
CN1041494C (zh) * 1993-01-01 1999-01-06 河南省中药研究所 用于治疗慢性缺血性心脏病的一种中药散剂胶囊
CN1074613A (zh) * 1993-01-18 1993-07-28 邱天道 心泰膏
CN1085083C (zh) * 1993-02-17 2002-05-22 山海丹企业集团西安中医多学科研究所 治疗心绞痛型冠心病的药物及生产方法
CN1067244C (zh) * 1996-02-17 2001-06-20 昆明制药股份有限公司 三七皂甙粉针剂
CN1242364A (zh) 1998-07-22 2000-01-26 中国医科大学 治疗消化性溃疡的丹参提取物f及其制备工艺
CN1129572C (zh) 1998-09-11 2003-12-03 中国科学院上海药物研究所 丹参多酚酸盐混合物及其制备方法和用途
CN1095363C (zh) * 1999-05-05 2002-12-04 方同华 精制血塞通注射液的生产工艺
CN1274600A (zh) * 1999-05-24 2000-11-29 周金龙 一种治疗瘫痪的药物及其制备方法
CN1095674C (zh) * 1999-06-18 2002-12-11 贺云青 一种治疗脑血管病及风湿类风湿病的中草药组合物
CN1363288A (zh) * 2001-01-10 2002-08-14 杨孟君 纳米消栓再造制剂药物及其制备方法
CN1368061A (zh) * 2001-01-31 2002-09-11 杨孟君 纳米消栓通络制剂药物及其制备方法
WO2002092109A1 (en) * 2001-05-14 2002-11-21 The Affiliated Hospital Of Chengdu University Of Traditional Chinese Medicine Herbal composition and its use
US6589572B2 (en) * 2001-06-14 2003-07-08 Medvill Co., Ltd. Hypertension-treatment and cholesterol-depressant composition comprising extract from mixture of Panax notoginseng and Salvia miltiorrhiza and method of preparing the same
US6616943B2 (en) * 2001-08-31 2003-09-09 Fountain Silver Limited Composition comprising Wenguanguo extracts and methods for preparing same
CN1229324C (zh) * 2001-09-26 2005-11-30 中国医学科学院药物研究所 丹参总酚酸的提取方法及其制剂的制法与用途
TWI275396B (en) * 2001-10-17 2007-03-11 Braingenesis Biotechnology Co Composition of traditional Chinese medicines for preventing and treating cerebrovascular disease
CN1349818A (zh) * 2001-10-24 2002-05-22 沈阳药科大学 复方丹参有效部位群及其缓释制剂与医药用途和制备方法
CN1352985A (zh) 2001-11-27 2002-06-12 沈阳药科大学 中药丹参有效部位及其缓释制剂与医药用途和制备方法
CN1248702C (zh) * 2002-02-07 2006-04-05 天津天士力制药股份有限公司 治疗冠心病心绞痛的中药制剂及其制备方法
CN1202103C (zh) 2002-05-23 2005-05-18 天津天士力制药股份有限公司 丹参总酚酸的制备方法

Also Published As

Publication number Publication date
EA009730B1 (ru) 2008-02-28
ES2383599T3 (es) 2012-06-22
EA200600636A1 (ru) 2006-08-25
WO2005051404A8 (en) 2006-04-27
DK1679058T3 (da) 2012-06-25
HK1089092A1 (en) 2006-11-24
PT1679058E (pt) 2012-06-28
LT2006027A (lt) 2007-03-26
EP1679058B1 (en) 2012-03-28
AU2004292351A1 (en) 2005-06-09
BRPI0414655B8 (pt) 2021-05-25
PL1679058T3 (pl) 2012-09-28
AP1908A (en) 2008-10-24
CA2538478C (en) 2013-02-19
AU2004292351B2 (en) 2009-11-19
CN100339085C (zh) 2007-09-26
SI1679058T1 (sl) 2012-07-31
BRPI0414655B1 (pt) 2017-03-07
SA04250309B1 (ar) 2009-12-22
KR20070028283A (ko) 2007-03-12
BRPI0414655A (pt) 2006-11-21
EP1679058A4 (en) 2009-12-09
WO2005051404A1 (fr) 2005-06-09
US20070053999A1 (en) 2007-03-08
CN1600319A (zh) 2005-03-30
JP4943846B2 (ja) 2012-05-30
ZA200603180B (en) 2007-01-31
ATE551100T1 (de) 2012-04-15
LT5433B (lt) 2007-07-25
EP1679058A1 (en) 2006-07-12
US7438935B2 (en) 2008-10-21
AP2006003596A0 (en) 2006-04-30
UA85065C2 (ru) 2008-12-25
JP2007505936A (ja) 2007-03-15
CA2538478A1 (en) 2005-06-09
MY144043A (en) 2011-07-29
NO334431B1 (no) 2014-03-03
NZ546654A (en) 2008-09-26

Similar Documents

Publication Publication Date Title
NO20061764L (no) En farmasoytisk sammensetning for behandling av kadiovaskulaere og cerebrovaskulaere sykdommer
Cakilcioglu et al. Ethnopharmacological survey of medicinal plants in Maden (Elazig-Turkey)
MXPA03005666A (es) Composicion herbal para angina pectoris, metodo para preparar la misma y sus usos.
AR071731A1 (es) Composiciones herbarias y metodos para el tratamiento de enfermedades hepaticas y metodos de obtencion
WO2009066303A3 (en) New synergistic phytochemical composition for the treatment of obesity
WO2008106979A3 (en) Pharmaceutical compositions comprising flavonoids and xylitol
EA201200892A1 (ru) Композиция для гигиены полости рта
JP2020511495A5 (no)
EA200600471A1 (ru) Лечение устойчивости к аспирину с использованием radix salviae multiorrhizae, его экстракта и композиции
Meng et al. Chemical constituents of Atractylodes chinensis (DC.) Koidz.
CL2008003154A1 (es) Proceso de obtencion de un extracto estandarizado de aleuterites moluccana; extracto estandarizado de aleurites moluccana; composicion farmaceutica que comprende el extracto; uso del extracto para tratar condiciones de dolor.
Sharma et al. Ethnopharmacological survey on bone healing plants with special references to Pholidota articulata and Coelogyne cristata (Orchidaceae) used in folk tradition of Kumaon, Uttarakhand, India
Li et al. Chemical constituents from Cymbaria dahurica L.(Scrophulariaceae)
JP2011527984A5 (no)
EP1981517A4 (en) PLANT COMPOSITION
Uma et al. Evaluation of hepatoprotective (preventive & curative) activity of leaves extract of ROSA Centifolia on experimental animal models
CN105456131A (zh) 一种抗肿消炎漱口水
HRP20070230B1 (en) Herbal composition for the prevention and treatmentofdiabetes mellitus type (i) and type (ii)
MX2007010360A (es) Composicion herbal para el tratamiento de psoriasis.
AR047501A1 (es) Tratamiento de resistencia a la aspirina con radix salviae miltiorrhizae su extracto y composicion
CN106822432A (zh) 一种治疗痔疮的中药配方
CN106822449A (zh) 一种补气中药配方
CN106822437A (zh) 一种治疗椎间盘突出的中药配方
CN106822450A (zh) 一种治疗百日咳的中药配方
CN106822438A (zh) 一种治疗骨质疏松的中药配方

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TASLY PHARMACEUTICAL GROUP CO LTD, CN

MM1K Lapsed by not paying the annual fees